Human papillomavirus infections in Cuban women with cervical intraepithelial neoplasia

Sexually Transmitted Diseases

Volumn 34, Issue 12, 2007, Pages 974-976

  Soto, Yudira ^a   Muné, Mayra ^a   Morales, Estrella ^b   Goicolea, Adibel ^b   Mora, Julio ^b   Sánchez, Lisset ^a   Ramirez, Rosa ^a   Alfonso, Melkis ^a   Kouri, Vivian ^a   Hengge, Ulrich R ^c  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Hospital Gineco Obstétrico 'Eusebio Hernández' Maternidad Obrera   (Cuba)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CUBA; DNA DETERMINATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 32; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; OPEN READING FRAME; QUESTIONNAIRE; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; VIRUS EXAMINATION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CUBA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARITY; POLYMERASE CHAIN REACTION; PREGNANCY; QUESTIONNAIRES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 36349011899     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31812e6b89     Document Type: Article

References (24)

1. Hagensee ME. Infection with human papillomavirus: Update on epidemiology, diagnosis and treatment. Curr Infect Dis Rep 2000; 2:18-24.
2. zur Hausen H. Papillomavirus infections - A major cause of human cancers. Biochim Biophys Acta 1996; 1288:55-78.
3. Muñoz N. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 2000; 19:1-5.
4. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: Global and national perspective. J Indian Med Assoc 2000; 98:49-52.
5. Brinton LA. Epidemiology of cervical cancer: Overview. IARC Sci Publ 1992; 119:3-23.
6. Yoshikawa H, Kawana T, Kitagawa K, et al. Detection and typing of multiple genital human papillomavirus by DNA amplification with consensus primers. Jpn J Cancer Res 1991; 82:524-531.
7. Kadish AS, Hagan RJ, Ritter DB, et al. Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum Pathol 1992; 23:1262-1269.
8. Jacobs MV, de Roda Husman AM, van den Brule AJ, et al. Group-specific differentiation between high and low risk human papillomavirus genotypes by general primer mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 3:901-905.
9. Tham KM, Chow VT, Singh P, et al. Diagnostic sensitivity of polymerase chain reaction and southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions. Am J Clin Pathol 1991; 95:638-646.
10. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91:226-236.
11. Kjaer S, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006; 66:10630-10636.
12. Castle PE, Solomon D, Schiffman M, et al. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005; 97:1066-1071.
13. Torroella-Kourí M, Morsberger S, Carrillo A, et al. HPV prevalence among Mexican women with neoplastic and abnormal cervixes. Gynecol Oncol 1998; 70:115-120.
14. Noronha V, Mello V, Villa L, et al. Human papillomavirus associated with uterine cervix lesions. Rev Soc Bras Med Trop 1999; 32:235-240.
15. Clavel C, Rihet S, Masure M, et al. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR. J Clin Pathol 1998; 51:38-43.
16. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-1278.
17. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2000; 183:8-15.
18. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
19. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-337.
20. Arora R, Kumar A, Prusty BK, et al. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Gynecol Reprod Biol 2005; 121:104-109.
21. Lombard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998; 16:2613-2619.
22. Burger MPM, Hollema H, Guw ASH, et al. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ 1993; 306:749-752.
23. Kjaer SK, van der Brule AJC, Bock JE, et al. Human papillomavirus - The most significance risk determinant of cervical intraepithelial neoplasia. A population-based prospective cohort study from Copenhagen. Int J Cancer 1996; 65:601-606.
24. Arbeit JM, Howley PM, Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 1996; 93:2930-2935.